Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors

Bobin Wu, Yanchun Yang, Xiangyu Qin, Shuzhen Zhang, Chaojun Jing, Changjin Zhu*, Bing Ma

*此作品的通讯作者

科研成果: 期刊稿件文章同行评审

74 引用 (Scopus)
Plum Print visual indicator of research metrics
  • Citations
    • Citation Indexes: 73
  • Captures
    • Readers: 15
see details

摘要

ARIs for diabetes: A series of 2-(3-benzyl-2-oxoquinoxalin-1(2H)-yl)acetic acid derivatives were designed and synthesized as inhibitors of aldose reductase (AR), a novel target for the treatment of diabetes complications. Most of the derivatives proved to be potent and selective, with IC50 values in the low nanomolar to micromolar range.

源语言英语
页(从-至)1913-1917
页数5
期刊ChemMedChem
8
12
DOI
出版状态已出版 - 12月 2013

指纹

探究 'Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors' 的科研主题。它们共同构成独一无二的指纹。

引用此

Wu, B., Yang, Y., Qin, X., Zhang, S., Jing, C., Zhu, C., & Ma, B. (2013). Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors. ChemMedChem, 8(12), 1913-1917. https://doi.org/10.1002/cmdc.201300324